Segment information

DSM's operating segments are Nutrition, Materials and the Innovation Center. DSM has segmented its operations by business activity from which revenues are earned and expenses incurred. These operating results are regularly reviewed by the entity's chief operating decision maker (CODM) to make decisions about resources to be allocated to the segment and assess its performance. DSM uses Adjusted EBITDA as the main indicator to evaluate the consolidated performance as well as the performance per segment. Discrete financial information is available for each identified segment. The accounting policies of the operating segments are the same as those described in the Summary of significant accounting policies. Transactions between segments are generally executed at market-based prices. Interest income, interest expense, and income tax expense or income are not allocated to segments as these amounts are not included in the measure of segment profit or loss reviewed by the CODM, or otherwise regularly provided to the CODM.

Nutrition serves the global industries for animal feed, food and beverages, pharmaceuticals, infant nutrition, dietary supplements, and personal care. It does so by the production of pure active ingredients, their incorporation into sophisticated forms, and the provision of tailored premixes and forward solutions.

Materials is a global player in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Furthermore, Materials is a global player in providing innovative, sustainable resins solutions for paints and industrial and optical fiber coatings, as well as the fiber Dyneema®.

The Innovation Center focuses on innovation and growth of DSM's existing core business through adjacent technologies via its Corporate Research Program as well as through the company's venturing and licensing activities. Additionally, it identifies and invests in new and innovative growth options. The Innovation Center is responsible for developing and extracting value from DSM's Emerging Business Areas.

Any consolidated activities outside the three reported segments are reported as 'Corporate Activities'. These mainly comprise operating and service activities as well as a number of costs that cannot be allocated to the clusters.

DSM does not have a single external customer that represents 10% or more of total sales.

Geographical information

2017
The Nether-lands
Rest of Western Europe
Eastern Europe
North America
Latin America
China
India
Japan
Rest of Asia
Rest of the world
Total
Net sales by origin
                     
In € million
2,193
2,560
182
1,430
669
1,023
82
123
286
84
8,632
In %
25
30
2
17
8
12
1
1
3
1
100
                       
Net sales by destination
                     
In € million
316
2,074
564
1,918
1,059
1,116
200
299
821
265
8,632
In %
4
24
7
22
12
13
2
3
10
3
100
                       
Workforce at year-end (headcount)
3,831
4,905
504
3,264
2,078
4,593
537
195
870
277
21,054
Average workforce (FTE)
3,735
4,676
469
3,204
2,066
4,572
504
194
846
267
20,533
                       
Intangible assets and Property, plant and equipment
                     
Capital expenditure
134
209
4
126
45
53
4
2
6
3
586
Carrying amount
1,674
1,692
31
1,864
387
547
19
37
97
23
6,371
                       
Total assets (total DSM)
4,656
2,530
141
2,739
877
1,110
104
139
403
103
12,802
                       
2018
Net sales by origin
                     
In € million
2,299
3,301
195
1,403
574
938
95
113
264
85
9,267
In %
25
36
2
15
6
10
1
1
3
1
100
                       
Net sales by destination
                     
In € million
405
2,229
597
2,070
1,081
1,131
233
322
906
293
9,267
In %
4
24
7
22
12
12
3
3
10
3
100
                       
Workforce at year-end (headcount)
3,827
5,069
523
3,281
2,214
4,104
556
204
904
295
20,977
Average workforce (FTE)
3,644
4,851
511
3,258
2,139
4,335
545
199
884
284
20,650
                       
Intangible assets and Property, plant and equipment
                     
Capital expenditure
150
208
7
121
36
116
3
3
6
3
653
Carrying amount
1,678
1,961
33
1,823
362
568
19
41
93
23
6,601
                       
Total assets (total DSM)
5,094
2,732
143
2,778
939
1,064
132
170
482
107
13,641

Business segments

2018
Nutrition
Materials
Innovation Center
Corporate
Activities
Elimina-
tions
Total
Financial performance
           
Net sales
6,137
2,913
172
45
-
9,267
Supplies to other clusters
46
9
19
-
(74)
-
             
Supplies
6,183
2,922
191
45
(74)
9,267
             
Adjusted EBITDA
1,407
512
8
(105)
-
1,822
EBITDA
1,379
490
7
(122)
-
1,754
Adjusted operating profit
1,111
383
(14)
(135)
-
1,345
Operating profit
1,050
362
(15)
(152)
-
1,245
             
Depreciation and amortization
291
128
22
28
-
469
Impairments
38
-
-
2
-
40
- of which included in APM adjustments
33
(1)
-
-
-
32
Additions to provisions
8
11
2
14
-
35
Result related to associates and joint ventures
3
-
(2)
128
-
129
R&D costs1
153
114
50
31
-
348
Wages, salaries and social security costs
965
334
74
270
-
1,643
             
Financial position
           
Total assets
7,201
2,293
735
3,412
-
13,641
Total liabilities
2,011
729
59
3,027
-
5,826
Capital employed at year-end
5,683
1,878
597
23
-
8,181
Capital expenditure
463
132
32
26
-
653
Share in equity of associates and joint ventures
54
3
71
77
-
205
             
Adjusted EBITDA margin (in %)
22.9
17.6
     
19.7
             
Workforce
           
Average in FTE
13,432
4,566
681
1,971
-
20,650
Year-end (headcount)
13,628
4,643
701
2,005
-
20,977

1 R&D costs relate to the functional area Research and development and exclude R&D costs included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.

Business segments

2017
Nutrition
Materials
Innovation Center
Corporate
Activities
Elimina-
tions
Total
Financial performance
           
Net sales
5,579
2,825
169
59
-
8,632
Supplies to other clusters
52
10
22
-
(84)
-
             
Supplies
5,631
2,835
191
59
(84)
8,632
             
Adjusted EBITDA
1,053
488
9
(105)
-
1,445
EBITDA
1,022
485
10
(169)
-
1,348
Adjusted operating profit
770
361
(30)
(144)
-
957
Operating profit
728
367
(40)
(209)
-
846
             
Depreciation and amortization
280
125
25
34
-
464
Impairments
14
(8)
26
6
-
38
- of which included in APM adjustments
11
(9)
11
1
-
14
Additions to provisions
17
-
6
71
-
94
Result related to associates and joint ventures
-
-
(103)
1,257
-
1,154
R&D costs1
127
112
63
32
-
334
Wages, salaries and social security costs
955
327
78
296
-
1,656
             
Financial position
           
Total assets
6,811
2,162
674
3,155
-
12,802
Total liabilities
1,900
696
70
3,071
-
5,737
Capital employed at year-end
5,420
1,786
562
(2)
-
7,766
Capital expenditure
407
124
43
12
-
586
Share in equity of associates and joint ventures
1
3
53
170
-
227
             
Adjusted EBITDA margin (in %)
18.9
17.3
     
16.7
             
Workforce
           
Average in FTE
13,243
4,472
639
2,179
-
20,533
Year-end (headcount)
13,676
4,635
685
2,058
-
21,054

1 R&D costs relate to the functional area Research and development and exclude R&D costs included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.